Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1969 Mar 8;1(5644):614–615. doi: 10.1136/bmj.1.5644.614

Controlled Trial of Dipyridamole in Cerebral Vascular Disease

Joan Acheson, G Danta, E C Hutchinson
PMCID: PMC1982429  PMID: 4885615

Abstract

A controlled double-blind study of the effect of dipyridamole was performed in 169 patients with established cerebral vascular disease. A dose of 400 mg. was used initially, given daily for an average of 14 months; the dose was then increased to 800 mg. daily for a further average period of 11 months. When the incidence of cerebral ischaemic episodes during treatment was compared in the drug-treated and placebo-treated groups no significant difference was found.

Full text

PDF
614

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Afonso S., O'Brien G. S. Enhancement of coronary vasodilator action of adenosine triphosphate by dipyridamole. Circ Res. 1967 Apr;20(4):403–408. doi: 10.1161/01.res.20.4.403. [DOI] [PubMed] [Google Scholar]
  2. CHIBA T. EXPERIMENTAL STUDIES ON THE EFFECTS OF PERSANTIN WITH NORMAL AND GO-DOGS. Bull Osaka Med Sch. 1963 Apr;9:106–128. [PubMed] [Google Scholar]
  3. DEGRAFF A. C., LYON A. F. Evaluation of dipyridamole (Persantin). Am Heart J. 1963 Mar;65:423–424. doi: 10.1016/0002-8703(63)90018-8. [DOI] [PubMed] [Google Scholar]
  4. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature. 1965 Oct 16;208(5007):255–257. doi: 10.1038/208255a0. [DOI] [PubMed] [Google Scholar]
  5. Emmons P. R., Harrison M. J., Honour A. J., Mitchell J. R. Effect of dipyridamole on human platelet behaviour. Lancet. 1965 Sep 25;2(7413):603–606. doi: 10.1016/s0140-6736(65)90515-5. [DOI] [PubMed] [Google Scholar]
  6. FAM W. M., RAGHEB S., HOESCHEN R. J. AUGMENTATION OF INTERCORONARY ANASTOMOSIS BY LONG-TERM ADMINISTRATION OF A VASODILATOR DRUG, DIPYRIDAMOLE (PERSANTIN). Can Med Assoc J. 1964 Apr 18;90:970–973. [PMC free article] [PubMed] [Google Scholar]
  7. FOULDS T., MACKINNON J. Controlled double-blind trial of "persantin" in treatment of angina pectoris. Br Med J. 1960 Sep 17;2(5202):835–835. doi: 10.1136/bmj.2.5202.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LAUDAHN G. [The effect of Persantin on heart muscle sarcosomes]. Experientia. 1961 Sep 15;17:415–416. doi: 10.1007/BF02157978. [DOI] [PubMed] [Google Scholar]
  9. LEIBERMAN A., GUGLIELMELLI S. PERSANTIN-- A DOUBLE BLIND STUDY. Angiology. 1964 Jun;15:290–292. doi: 10.1177/000331976401500608. [DOI] [PubMed] [Google Scholar]
  10. Meesmann W., Bachmann G. W. Pharmakodynamisch induzierte Entwicklung von Koronar-Kollateralen in Abhängigkeit von der Dosis. Arzneimittelforschung. 1966 Apr;16(4):501–509. [PubMed] [Google Scholar]
  11. NEWHOUSE M. T., MCGREGOR M. LONG TERM DIPYRIDAMOLE THERAPY OF ANGINA PECTORIS. Am J Cardiol. 1965 Aug;16:234–237. doi: 10.1016/0002-9149(65)90478-9. [DOI] [PubMed] [Google Scholar]
  12. SIESS M. [Function and energy metabolism of the exhausted heart muscle under the effects of 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyrimidine]. Arzneimittelforschung. 1962 Jul;12:683–691. [PubMed] [Google Scholar]
  13. SOLOFF L. A., GIMENEZ J. L., WINTERS W. L., Jr Experimental and clinical observations on 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d) pyrimidine (Persantin). Am J Med Sci. 1962 Jun;243:783–789. doi: 10.1097/00000441-196206000-00009. [DOI] [PubMed] [Google Scholar]
  14. Sbar S., Schlant R. C. Dipyridamole in the treatment of angina pectoris. A double-blind evaluation. JAMA. 1967 Sep 11;201(11):865–867. [PubMed] [Google Scholar]
  15. Sullivan J. M., Harken D. E., Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med. 1968 Sep 12;279(11):576–580. doi: 10.1056/NEJM196809122791104. [DOI] [PubMed] [Google Scholar]
  16. Sullivan J. M., Kagnoff M. F., Gorlin R. Reduction of platelet adhesiveness in patients with coronary artery disease. Am J Med Sci. 1968 May;255:292–295. doi: 10.1097/00000441-196805000-00004. [DOI] [PubMed] [Google Scholar]
  17. VINEBERG A. M., CHARI R. S., PIFARRE R., MERCIER C. The effect of persantin on intercoronary collateral circulation and survival during gradual experimental coronary occlusion. A preliminary report. Can Med Assoc J. 1962 Aug 18;87:336–345. [PMC free article] [PubMed] [Google Scholar]
  18. ZION M. M., BRADLOW B. A. A controlled clinical trial of 'persantin' (R A 8) in angina pectoris. S Afr Med J. 1961 Jan 7;35:11–13. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES